These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 12147333)

  • 1. The angiotensin 1-converting enzyme insertion (I)/deletion (D) polymorphism does not influence the extent of amyloid or tau pathology in patients with sporadic Alzheimer's disease.
    Lendon CL; Thaker U; Harris JM; McDonagh AM; Lambert JC; Chartier-Harlin MC; Iwatsubo T; Pickering-Brown SM; Mann DM
    Neurosci Lett; 2002 Aug; 328(3):314-8. PubMed ID: 12147333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin-converting enzyme 2 is reduced in Alzheimer's disease in association with increasing amyloid-β and tau pathology.
    Kehoe PG; Wong S; Al Mulhim N; Palmer LE; Miners JS
    Alzheimers Res Ther; 2016 Nov; 8(1):50. PubMed ID: 27884212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic associations between cathepsin D exon 2 C-->T polymorphism and Alzheimer's disease, and pathological correlations with genotype.
    Davidson Y; Gibbons L; Pritchard A; Hardicre J; Wren J; Tian J; Shi J; Stopford C; Julien C; Thompson J; Payton A; Thaker U; Hayes AJ; Iwatsubo T; Pickering-Brown SM; Pendleton N; Horan MA; Burns A; Purandare N; Lendon CL; Neary D; Snowden JS; Mann DM
    J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):515-7. PubMed ID: 16543533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A polymorphism in the angiotensin 1-converting enzyme gene is associated with damage to cerebral cortical white matter in Alzheimer's disease.
    Tian J; Shi J; Bailey K; Harris JM; Pritchard A; Lambert JC; Chartier-Harlin MC; Pickering-Brown SM; Lendon CL; Mann DM
    Neurosci Lett; 2004 Jan; 354(2):103-6. PubMed ID: 14698449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tau load is associated with apolipoprotein E genotype and the amount of amyloid beta protein, Abeta40, in sporadic and familial Alzheimer's disease.
    Thaker U; McDonagh AM; Iwatsubo T; Lendon CL; Pickering-Brown SM; Mann DM
    Neuropathol Appl Neurobiol; 2003 Feb; 29(1):35-44. PubMed ID: 12581338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative balance in Alzheimer's disease: relationship to APOE, Braak tangle stage, and the concentrations of soluble and insoluble amyloid-β.
    Tayler H; Fraser T; Miners JS; Kehoe PG; Love S
    J Alzheimers Dis; 2010; 22(4):1363-73. PubMed ID: 20930272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A polymorphism within intron 11 of the tau gene is not increased in frequency in patients with sporadic Alzheimer's disease, nor does it influence the extent of tau pathology in the brain.
    Green EK; Thaker U; McDonagh AM; Iwatsubo T; Lambert JC; Chartier-Harlin MC; Harris JM; Pickering-Brown SM; Lendon CL; Mann DM
    Neurosci Lett; 2002 May; 324(2):113-6. PubMed ID: 11988340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Senile dementia associated with amyloid beta protein angiopathy and tau perivascular pathology but not neuritic plaques in patients homozygous for the APOE-epsilon4 allele.
    Vidal R; Calero M; Piccardo P; Farlow MR; Unverzagt FW; Méndez E; Jiménez-Huete A; Beavis R; Gallo G; Gomez-Tortosa E; Ghiso J; Hyman BT; Frangione B; Ghetti B
    Acta Neuropathol; 2000 Jul; 100(1):1-12. PubMed ID: 10912914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of apolipoprotein E in Alzheimer's disease and its significance].
    He SR; Liu DG; Wang S; Xia YJ
    Zhonghua Bing Li Xue Za Zhi; 2005 Sep; 34(9):556-60. PubMed ID: 16468304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin converting enzyme insertion/deletion polymorphism in sporadic and familial Alzheimer's disease and longevity.
    Nacmias B; Bagnoli S; Tedde A; Cellini E; Bessi V; Guarnieri B; Ortensi L; Piacentini S; Bracco L; Sorbi S
    Arch Gerontol Geriatr; 2007; 45(2):201-6. PubMed ID: 17182125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of association between angiotensin converting enzyme polymorphism and sporadic Alzheimer's disease.
    Monastero R; Caldarella R; Mannino M; Cefalù AB; Lopez G; Noto D; Camarda C; Camarda LK; Notarbartolo A; Averna MR; Camarda R
    Neurosci Lett; 2002 Dec; 335(2):147-9. PubMed ID: 12459519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oligomeric Abeta in Alzheimer's disease: relationship to plaque and tangle pathology, APOE genotype and cerebral amyloid angiopathy.
    van Helmond Z; Miners JS; Kehoe PG; Love S
    Brain Pathol; 2010 Mar; 20(2):468-80. PubMed ID: 19725829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Significance for etiological theories of Alzheimer's disease.
    Harrington CR; Louwagie J; Rossau R; Vanmechelen E; Perry RH; Perry EK; Xuereb JH; Roth M; Wischik CM
    Am J Pathol; 1994 Dec; 145(6):1472-84. PubMed ID: 7992850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profiles of β-Amyloid Peptides and Key Secretases in Brain Autopsy Samples Differ with Sex and APOE ε4 Status: Impact for Risk and Progression of Alzheimer Disease.
    Nyarko JNK; Quartey MO; Pennington PR; Heistad RM; Dea D; Poirier J; Baker GB; Mousseau DD
    Neuroscience; 2018 Mar; 373():20-36. PubMed ID: 29331531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preferential deposition of amyloid beta protein (Abeta) in the form Abeta40 in Alzheimer's disease is associated with a gene dosage effect of the apolipoprotein E E4 allele.
    Mann DM; Iwatsubo T; Pickering-Brown SM; Owen F; Saido TC; Perry RH
    Neurosci Lett; 1997 Jan; 221(2-3):81-4. PubMed ID: 9121705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The spectrum of preclinical Alzheimer's disease pathology and its modulation by ApoE genotype.
    Pletnikova O; Kageyama Y; Rudow G; LaClair KD; Albert M; Crain BJ; Tian J; Fowler D; Troncoso JC
    Neurobiol Aging; 2018 Nov; 71():72-80. PubMed ID: 30099348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased brain beta-amyloid load, phosphorylated tau, and risk of Alzheimer disease associated with an intronic CYP46 polymorphism.
    Papassotiropoulos A; Streffer JR; Tsolaki M; Schmid S; Thal D; Nicosia F; Iakovidou V; Maddalena A; Lütjohann D; Ghebremedhin E; Hegi T; Pasch T; Träxler M; Brühl A; Benussi L; Binetti G; Braak H; Nitsch RM; Hock C
    Arch Neurol; 2003 Jan; 60(1):29-35. PubMed ID: 12533085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletion/insertion polymorphism of the angiotensin-converting enzyme gene and white matter hyperintensities in dementia: A pilot study.
    Purandare N; Oude Voshaar RC; Davidson Y; Gibbons L; Hardicre J; Byrne J; McCollum C; Jackson A; Burns A; Mann DM
    J Am Geriatr Soc; 2006 Sep; 54(9):1395-400. PubMed ID: 16970648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction between apolipoprotein-E and angiotensin-converting enzyme genotype in Alzheimer's disease.
    Isbir T; Agaçhan B; Yilmaz H; Aydin M; Kara I; Eker D; Eker E
    Am J Alzheimers Dis Other Demen; 2001; 16(4):205-10. PubMed ID: 11501342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ACE I/D polymorphism is a risk factor of Alzheimer's disease but not of vascular dementia.
    Kölsch H; Jessen F; Freymann N; Kreis M; Hentschel F; Maier W; Heun R
    Neurosci Lett; 2005 Mar; 377(1):37-9. PubMed ID: 15722183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.